Salvia reuterana Extract Prevents Formation of Advanced Glycation End Products: An In Vitro Study

Authors

  • Ali Sonboli Department of Biology, Medicinal Plants and Drug Research Institute, Shahid Beheshti University, Tehran, Iran
  • Mohammad Ali Esmaeili Department of Biology, Medicinal Plants and Drug Research Institute, Shahid Beheshti University, Tehran, Iran
  • Mohammad Reza Kanani Department of Biology, Medicinal Plants and Drug Research Institute, Shahid Beheshti University, Tehran, Iran
Abstract:

       In this study, we examined the antioxidant activities of methanolic extract of three endemic species of Salvia from Iran (S. lachnocalyx, S. reuterana and S. sahendica) employing various established in vitro systems including ferric reducing antioxidant power, Trolox equivalent antioxidant capacity assay and scavenging of 1,1-diphenyl-2-picrylhydrazyl radical. The results revealed that S. reuterana extract possess the highest antioxidant activity, total phenolic and flavonoid contents among these three species. Regarding the link between glycation and oxidation, we proposed that the S. reuterana extract might possess significant in vitro antiglycation activities as well. The S. reuterana extract also showed strong inhibitory effects on the production of Amadori products and advanced glycation end products from bovine serum albumin in the presence of fructose in term of protein carbonyl formation and thiol oxidation. The structural changes of bovine serum albumin (BSA) with fructose, in the presence of S. reuterana extract were evaluated by circular dichroism and fluorescence techniques. Regarding enhancing the helicity of the protein and preventing helix decrement in the secondary structure of BSA in the presence of fructose, it can be concluded that S. reuterana extract and its constituents may act as an anti-glycation agent for bovine serum albumin.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

salvia reuterana extract prevents formation of advanced glycation end products: an in vitro study

in this study, we examined the antioxidant activities of methanolic extract of three endemic species of salvia from iran (s. lachnocalyx, s. reuterana and s. sahendica) employing various established in vitro systems including ferric reducing antioxidant power, trolox equivalent antioxidant capacity assay and scavenging of 1,1-diphenyl-2-picrylhydrazyl radical. the results revealed that s. reute...

full text

Advanced glycation end products

Aging is the progressive accumulation of damage to an organism over time leading to disease and death. Aging research has been very intensive in the last years aiming at characterizing the pathophysiology of aging and finding possibilities to fight age-related diseases. Various theories of aging have been proposed. In the last years advanced glycation end products (AGEs) have received particula...

full text

Preparation of advanced glycation end products in vitro.

Preparation of advanced glycation end products in vitro Sir, With great interest we read the article by Chang et al. [1] on the enhancement of epithelial sodium channel mRNA expression and protein level in renal cortical collecting duct (CCD) cells by advanced glycation end products (AGEs). The authors show that AGEs can increase sodium uptake in CCD cells in a dose-dependent way, providing a n...

full text

In Vitro Inhibitory Activity of Acca sellowiana Fruit Extract on End Products of Advanced Glycation

INTRODUCTION Hyperglycemia plays an important role in the pathogenesis of diabetic complications, as it increases protein glycation, as well as the progressive accumulation of advanced glycation end products (AGEs), which are complex structures that produce fluorescence. The glycation reaction raises the levels of protein carbonyl, N ε-(carboxymethyl)lysine (CML), and fructosamine and decreases...

full text

Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.

BACKGROUND Advanced glycation end products (AGE) accumulate in human tissue proteins during aging, particularly under hyperglycemia conditions. AGEs induce oxidative stress and inflammation via the receptor for AGEs (RAGE) and soluble RAGE (sRAGE) can neutralize the effects mediated by RAGE-ligand engagement. METHODS We examined the association between N(ε)-(carboxymethyl)lysine (CML), a prom...

full text

Advanced glycation end products in diabetic corneas.

PURPOSE Corneal complications are often associated with diabetes mellitus and can be vision threatening. Corneas in diabetic patients are exposed to increased glucose concentration despite cornea's avascular property, and this condition may contribute to the accumulation of advanced glycation end products (AGEs). The focus of this study was to examine the role of AGEs in the pathogenesis of dia...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 1

pages  33- 50

publication date 2010-01-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023